“Since January, I have spent every day alone in my laboratory, urgently trying to find a cure for COVID‑19,” says structural biologist and pharmacologist Li Hua, who lives on campus at Huazhong University of Science and Technology in Wuhan, China, the epicentre of the pandemic. Li’s colleagues, who had left for the Lunar New Year holiday, could not return during the lockdown and he is currently the only one who can access the lab. Now the lockdown there has ended, Li is working with collaborators in Shanghai to test the efficacy of the drug candidates he identified. (Nature | 3 min read)
Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
domingo, 19 de abril de 2020
Working in isolation to find a cure for COVID-19
Working in isolation to find a cure for COVID-19

“Since January, I have spent every day alone in my laboratory, urgently trying to find a cure for COVID‑19,” says structural biologist and pharmacologist Li Hua, who lives on campus at Huazhong University of Science and Technology in Wuhan, China, the epicentre of the pandemic. Li’s colleagues, who had left for the Lunar New Year holiday, could not return during the lockdown and he is currently the only one who can access the lab. Now the lockdown there has ended, Li is working with collaborators in Shanghai to test the efficacy of the drug candidates he identified. (Nature | 3 min read)
“Since January, I have spent every day alone in my laboratory, urgently trying to find a cure for COVID‑19,” says structural biologist and pharmacologist Li Hua, who lives on campus at Huazhong University of Science and Technology in Wuhan, China, the epicentre of the pandemic. Li’s colleagues, who had left for the Lunar New Year holiday, could not return during the lockdown and he is currently the only one who can access the lab. Now the lockdown there has ended, Li is working with collaborators in Shanghai to test the efficacy of the drug candidates he identified. (Nature | 3 min read)
No hay comentarios:
Publicar un comentario